Related Experiment Video

Updated: Jun 16, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

Relationship between renal dysfunction and severity of coronary artery disease in Japanese patients

Arihiro Kiyosue1, Yasunobu Hirata, Jiro Ando

  • 1Department of Cardiovascular Medicine, Graduate School of Medicine, University of Tokyo, Tokyo, Japan.

Circulation Journal : Official Journal of the Japanese Circulation Society
|February 18, 2010
PubMed

Insights

Chronic kidney disease (CKD) is linked to more severe coronary artery disease (CAD). Worsening kidney function is associated with advanced CAD, highlighting CAD as a risk factor for renal dysfunction.

Area of Science:

  • Cardiology
  • Nephrology
  • Renal Function
  • Coronary Artery Disease

Background:

  • Investigated the link between renal dysfunction and coronary artery disease (CAD) severity.
  • Examined 572 patients over a 3-year period.

Purpose of the Study:

  • To determine the relationship between estimated glomerular filtration rate (eGFR) and the extent of coronary artery disease.
  • To assess the impact of CAD severity on renal function prognosis.

Main Methods:

  • Stratified patients into three eGFR groups: normal (>75), mild reduction (60-75), and chronic kidney disease (CKD) (<60).
  • Graded CAD severity by the number of stenotic coronary arteries.
  • Utilized multivariate analysis to identify independent associations.

Main Results:

  • Patients with CKD exhibited a significantly higher number of stenotic coronary arteries compared to other groups (1.69 vs. 1.35 and 1.22).
  • A significant association was found between a greater deterioration in eGFR and more severe CAD (1.61 vs. 1.20 stenotic vessels).
  • CAD severity independently predicted worsening eGFR.

Conclusions:

  • CKD patients present with more severe coronary artery disease, potentially explaining higher cardiovascular event rates.
  • Severe CAD is associated with a poor prognosis for renal function.
  • Coronary artery disease is an independent risk factor for the progression of renal dysfunction.
Abstract

Related Concept Videos

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...